Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Agnieszka Potęga, Barbara Fedejko-Kap & Zofia Mazerska. (2016) Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by anti-tumor triazoloacridinone C-1305. Xenobiotica 46:12, pages 1056-1065.
Read now
Read now
Articles from other publishers (17)
Lisard Iglesias-Carres, Sydney A. Chadwick-Corbin, Michael G. Sweet & Andrew P. Neilson. (2023) Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3. The Journal of Nutritional Biochemistry 120, pages 109428.
Crossref
Crossref
Tanuja T. Yadav, Manikanta Murahari, G.J. Peters & Mayur YC. (2022) A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships. European Journal of Medicinal Chemistry 239, pages 114527.
Crossref
Crossref
Slobodan P. Rendić, Rachel D. Crouch & F. Peter Guengerich. (2022) Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. Archives of Toxicology 96:8, pages 2145-2246.
Crossref
Crossref
Marta Świtalska, Beata Filip‐Psurska, Magdalena Milczarek, Mateusz Psurski, Adrianna Moszyńska, Aleksandra M. Dąbrowska, Małgorzata Gawrońska, Karol Krzymiński, Maciej Bagiński, Rafał Bartoszewski & Joanna Wietrzyk. (2022) Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis. Journal of Cellular and Molecular Medicine 26:14, pages 3950-3964.
Crossref
Crossref
Lisard Iglesias-Carres, Michael D. Hughes, Cortney N. Steele, Monica A. Ponder, Kevin P. Davy & Andrew P. Neilson. (2021) Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation. The Journal of Nutritional Biochemistry 91, pages 108600.
Crossref
Crossref
Tomomi Taniguchi-Takizawa, Harutoshi Kato, Makiko Shimizu & Hiroshi Yamazaki. (2021) Predicted Contributions of Flavin-containing Monooxygenases to the N-oxygenation of Drug Candidates Based on their Estimated Base Dissociation Constants. Current Drug Metabolism 22:3, pages 208-214.
Crossref
Crossref
Agnieszka Potęga, Dorota Żelaszczyk & Zofia Mazerska. (2020) Electrochemical and in silico approaches for liver metabolic oxidation of antitumor-active triazoloacridinone C-1305. Journal of Pharmaceutical Analysis 10:4, pages 376-384.
Crossref
Crossref
Tomasz Laskowski, Witold Andrałojć, Jakub Grynda, Paulina Gwarda, Jan Mazerski & Zofia Gdaniec. (2020) A strong preference for the TA/TA dinucleotide step discovered for an acridine-based, potent antitumor dsDNA intercalator, C-1305: NMR-driven structural and sequence-specificity studies. Scientific Reports 10:1.
Crossref
Crossref
Monika Pawłowska, Anna Kwaśniewska, Zofia Mazerska & Ewa Augustin. (2020) Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs’ Cytotoxicity, Metabolism and Cellular Response. International Journal of Molecular Sciences 21:11, pages 3954.
Crossref
Crossref
Patrizia Haegler, Lorenz Joerin, Stephan Krähenbühl & Jamal Bouitbir. (2017) Hepatocellular Toxicity of Imidazole and Triazole Antimycotic Agents. Toxicological Sciences 157:1, pages 183-195.
Crossref
Crossref
Ewa Augustin, Anna Skwarska, Anna Weryszko, Iwona Pelikant, Ewa Sankowska & Barbara Borowa-Mazgaj. (2015) The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells. Acta Pharmacologica Sinica 36:3, pages 385-399.
Crossref
Crossref
Ewa Augustin, Magdalena Niemira, Adam Hołownia & Zofia Mazerska. (2014) CYP3A4-dependent cellular response does not relate to CYP3A4-catalysed metabolites of C-1748 and C-1305 acridine antitumor agents in HepG2 cells. Cell Biology International 38:11, pages 1291-1303.
Crossref
Crossref
Magdalena Niemira, Jarosław Dastych & Zofia Mazerska. (2013) Pregnane X receptor dependent up-regulation of CYP2C9 and CYP3A4 in tumor cells by antitumor acridine agents, C-1748 and C-1305, selectively diminished under hypoxia. Biochemical Pharmacology 86:2, pages 231-241.
Crossref
Crossref
Monika Pawlowska, Rong Chu, Barbara Fedejko-Kap, Ewa Augustin, Zofia Mazerska, Anna Radominska-Pandya & Timothy C. Chambers. (2013) Metabolic Transformation of Antitumor Acridinone C-1305 but Not C-1311 via Selective Cellular Expression of UGT1A10 Increases Cytotoxic Response: Implications for Clinical Use. Drug Metabolism and Disposition 41:2, pages 414-421.
Crossref
Crossref
Ewa Augustin, Barbara Borowa-Mazgaj, Agnieszka Kikulska, Milena Kordalewska & Monika Pawłowska. (2012) CYP3A4 overexpression enhances the cytotoxicity of the antitumor triazoloacridinone derivative C-1305 in CHO cells. Acta Pharmacologica Sinica 34:1, pages 146-156.
Crossref
Crossref
Barbara Fedejko-Kap, Stacie M. Bratton, Moshe Finel, Anna Radominska-Pandya & Zofia Mazerska. (2012) Role of Human UDP-Glucuronosyltransferases in the Biotransformation of the Triazoloacridinone and Imidazoacridinone Antitumor Agents C-1305 and C-1311: Highly Selective Substrates for UGT1A10. Drug Metabolism and Disposition 40:9, pages 1736-1743.
Crossref
Crossref
Christian Bailly. (2012) Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy. Chemical Reviews 112:7, pages 3611-3640.
Crossref
Crossref